Cochrane · systematic review · CD002878

Chronic non‐invasive ventilation for chronic obstructive pulmonary disease

Raveling, T, Vonk, J, Struik, FM, et al. · Cochrane Database of Systematic Reviews · 2021 · Cochrane Library

Airways2 versionsAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
17
current version
GRADE rated
17
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 5 · 29.4%Low 6 · 35.3%Moderate 3 · 17.6%High 3 · 17.6%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Current version only

Summary of Findings Table ‐ Chronic non‐invasive ventilation compared to standard treatment for people with stable COPD

Population: stable COPD
CD002878.PUB3 (current) · 9 questions
OutcomeEffectEvidenceStatus / GRADE
Change in arterial partial pressure of oxygen
Summary of Findings Table ‐ Chronic non‐invasive ventilation vs standard treatment
no estimate extracted9 studies · 271 participantsModerate
Downgraded: risk of bias, imprecision, inconsistency
Change in arterial partial pressure of oxygen
Summary of Findings Table ‐ Chronic non‐invasive ventilation vs standard treatment
no estimate extracted3 studies · 171 participantsLow
Downgraded: risk of bias, imprecision, inconsistency
Change in arterial partial pressure of carbon dioxide
Summary of Findings Table ‐ Chronic non‐invasive ventilation vs standard treatment
no estimate extracted11 studies · 475 participantsHigh
Change in arterial partial pressure of carbon dioxide
Summary of Findings Table ‐ Chronic non‐invasive ventilation vs standard treatment
no estimate extracted4 studies · 232 participantsHigh
Change in 6‐minute walking distance
Summary of Findings Table ‐ Chronic non‐invasive ventilation vs standard treatment
no estimate extracted8 studies · 330 participantsLow
Downgraded: risk of bias, imprecision, inconsistency
Change in 6‐minute walking distance
Summary of Findings Table ‐ Chronic non‐invasive ventilation vs standard treatment
no estimate extracted3 studies · 134 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency
Change in the health‐related quality of life
Summary of Findings Table ‐ Chronic non‐invasive ventilation vs standard treatment
no estimate extracted5 studies · 259 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency
Change in the health‐related quality of life
Summary of Findings Table ‐ Chronic non‐invasive ventilation vs standard treatment
no estimate extracted4 studies · 200 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency
All‐cause mortality
Summary of Findings Table ‐ Chronic non‐invasive ventilation vs standard treatment
HR 0.75 [0.58, 0.97]3 studies · 405 participantsModerate
Downgraded: risk of bias, imprecision, inconsistency

Summary of Findings Table ‐ Chronic non‐invasive ventilation compared to standard treatment following a severe exacerbation for people with severe COPD

Population: post‐exacerbation COPD
CD002878.PUB3 (current) · 8 questions
OutcomeEffectEvidenceStatus / GRADE
Change in arterial partial pressure of oxygen
Summary of Findings Table ‐ Chronic non‐invasive ventilation vs standard treatment following a severe exacerbation
no estimate extracted3 studies · 234 participantsLow
Downgraded: risk of bias, imprecision, inconsistency
Change in arterial partial pressure of oxygen
Summary of Findings Table ‐ Chronic non‐invasive ventilation vs standard treatment following a severe exacerbation
no estimate extracted3 studies · 170 participantsLow
Downgraded: risk of bias, imprecision, inconsistency
Change in arterial partial pressure of carbon dioxide
Summary of Findings Table ‐ Chronic non‐invasive ventilation vs standard treatment following a severe exacerbation
no estimate extracted3 studies · 241 participantsModerate
Downgraded: risk of bias, imprecision, inconsistency
Change in arterial partial pressure of carbon dioxide
Summary of Findings Table ‐ Chronic non‐invasive ventilation vs standard treatment following a severe exacerbation
no estimate extracted3 studies · 175 participantsHigh
Change in the health‐related quality of life
Summary of Findings Table ‐ Chronic non‐invasive ventilation vs standard treatment following a severe exacerbation
no estimate extracted2 studies · 219 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency
Change in the health‐related quality of life
Summary of Findings Table ‐ Chronic non‐invasive ventilation vs standard treatment following a severe exacerbation
no estimate extracted2 studies · 164 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency
Admission‐free survival
Summary of Findings Table ‐ Chronic non‐invasive ventilation vs standard treatment following a severe exacerbation
HR 0.71 [0.54, 0.94]2 studies · 317 participantsLow
Downgraded: risk of bias, imprecision, inconsistency
All‐cause mortality
Summary of Findings Table ‐ Chronic non‐invasive ventilation vs standard treatment following a severe exacerbation
HR 0.97 [0.74, 1.28]2 studies · 318 participantsLow
Downgraded: risk of bias, imprecision, inconsistency

Nocturnal non‐invasive positive pressure ventilation compared with standard treatment for severe COPD

Population: adults with severe COPD
CD002878.PUB2 · 5 questions
OutcomeEffectEvidenceStatus / GRADE
Arterial blood gas tension: PaO2 after 3 months mmHg
Nocturnal non‐invasive positive pressure ventilation vs standard treatment
no estimate extracted6 studies · 162 participantsModerate
Arterial blood gas tension: PaCO2 after 3 months mmHg
Nocturnal non‐invasive positive pressure ventilation vs standard treatment
no estimate extracted6 studies · 162 participantsModerate
6MWD after 3 months metres
Nocturnal non‐invasive positive pressure ventilation vs standard treatment
no estimate extracted3 studies · 40 participantsLow
Quality of life: SGQR after 12 months total score on a scale from 0 to 100
Nocturnal non‐invasive positive pressure ventilation vs standard treatment
no estimate extracted2 studies · 103 participantsLow
Lung function: FEV1 after 3 months litres
Nocturnal non‐invasive positive pressure ventilation vs standard treatment
no estimate extracted5 studies · 83 participantsLow